Mounjaro®
Starting from £179.99/mo
Start journey Learn moreVitamin B12 injections do not cause weight loss. No clinical trial has shown that injecting B12 produces meaningful fat reduction in people who are not already deficient in the vitamin. If you have seen clinics offering B12 shots as a weight-loss treatment, that claim is not supported by evidence from any UK regulatory or clinical body. That said, there is a real and specific reason B12 injections come up in weight-loss conversations, and it is worth understanding properly. When a genuine B12 deficiency is corrected, people often notice improved energy and reduced fatigue — which can make exercise feel less effortful. That is a wellness benefit, not a metabolic fat-burning effect. If you are looking at licensed weight-loss injections with a clinical evidence base behind them, GLP-1 medicines such as tirzepatide and semaglutide work through an entirely different and well-documented mechanism. As prescription-only medicines, they require a clinical assessment before a prescriber can approve them.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Walk past enough wellness clinics and you will see vitamin B12 listed alongside phrases like "metabolism boost" and "fat-burning shot". It sounds plausible. B12 is involved in energy metabolism (it helps the body convert food into usable fuel) so the leap to "B12 injections accelerate weight loss" feels logical. It is not accurate.
What B12 actually does in energy metabolism is act as a co-factor in reactions that process carbohydrates, fats and proteins. Without adequate B12, those reactions slow down. But this is a corrective function, not an accelerative one. Topping up B12 in someone who already has normal levels does not speed up metabolism beyond baseline. The NHS confirms that B12 supplements are unlikely to affect energy or weight in people who are not deficient. There is no MHRA-licensed indication for B12 as a weight-loss medicine, and NICE has not appraised it for that use.
The reason this myth persists is partly because correcting a deficiency does produce a noticeable effect. People who were severely low on B12 and then receive injections often describe feeling more energetic, less breathless and more capable of physical activity. That is real, but it is the return to normal, not a treatment effect beyond normal. For anyone with normal B12 levels, injections deliver no comparable benefit. The body is remarkably efficient at excreting water-soluble vitamins it does not need.
If you want to understand whether B12 injections might have any role alongside other treatment, this page looks at that question in more depth.
There are legitimate medical reasons for B12 injections. Pernicious anaemia, certain gastrointestinal conditions that impair absorption, and some post-bariatric-surgery situations can all result in deficiency that oral supplements cannot reliably correct. In those cases, intramuscular hydroxocobalamin injections are prescribed by a GP, not sold by wellness clinics. That is an important distinction.
The overlap with weight loss comes from two directions. First, people on calorie-restricted diets sometimes develop nutritional shortfalls, including B12, particularly if they are reducing animal-product intake. Second, GLP-1 medicines such as Mounjaro (tirzepatide) and Wegovy (semaglutide) reduce appetite significantly, which can reduce overall food intake to the point where micronutrient intake needs monitoring. A prescriber reviewing your progress may check B12 among other markers, not because B12 drives the weight loss, but because adequate nutrition matters when you are eating less.
This is also why the potential benefits discussed around B12 in weight-loss contexts are really about supporting the conditions for treatment to work, rather than producing weight loss directly. It is a supporting role, not the lead.
If you think you might have a deficiency, your GP can test your serum B12 level and discuss whether injections are appropriate. That is the clinically correct route.
GLP-1 medicines work through a mechanism with decades of research behind it, and they carry UK marketing authorisations specifically for weight management. Mounjaro (tirzepatide) activates both GIP and GLP-1 receptors in the gut, slowing gastric emptying and significantly reducing appetite. Wegovy (semaglutide) acts on the GLP-1 receptor alone. Both have been shown in large clinical trials to produce meaningful, sustained weight reduction when combined with dietary changes and increased activity.
In SURMOUNT-1, published in the New England Journal of Medicine, tirzepatide at its highest dose produced average body-weight reductions of around 20 to 21 percent over 72 weeks. Semaglutide 2.4mg produced around 15 percent average weight loss in the STEP 1 trial. These are not energy-level corrections. They are clinically significant reductions driven by changes in appetite signalling and gastric function.
Both medicines are prescription-only, which means a qualified prescriber must assess your health, medical history and current medicines before approval. That is a legal requirement, not a bureaucratic inconvenience. For more context on how the full range of options compares, this overview of weight-loss injections in the UK sets them out clearly.
Practically speaking, GLP-1 pens are kept in the fridge at home (the door shelf works well) and taken once a week on a consistent day. The routine is straightforward once established, and prescribers guide patients through any early side effects.
The UK has a clear framework for this. The MHRA licences medicines based on evidence from clinical trials. NICE appraises them for cost-effectiveness and recommends them for NHS use. The NHS page on tirzepatide reflects that evidence base. B12 injections for weight loss appear nowhere in that framework because the evidence has not supported that use.
Clinics offering B12 "fat-burning" shots are selling a wellness service, not a licensed medicine for weight management. That does not make B12 injections inherently dangerous, but it does mean you should be sceptical of the weight-loss framing. If you are based locally and weighing up your options, our page covering weight loss injections in Southampton explains what is available and how to access it. The patient experiences reported around B12 injections and weight loss are worth reading with that distinction in mind.
If weight management is your goal, the treatments with the evidence behind them are tirzepatide (Mounjaro) and semaglutide (Wegovy). Both require a private prescription unless you meet NHS eligibility criteria, which are currently strict and phased. For anyone considering either, a free consultation with a GPhC-registered prescriber is the place to start. Our clinical team at nume reviews every consultation personally. Start your free consultation at our treatment page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.